CDC/HRSA Advisory Committee on HIV and STD Prevention and Treatment (CHACHSPT), 59793 [E6-16739]

Download as PDF Federal Register / Vol. 71, No. 196 / Wednesday, October 11, 2006 / Notices Dated: October 4, 2006. Joan F. Karr, Acting Reports Clearance Officer, Centers for Disease Control and Prevention. [FR Doc. E6–16746 Filed 10–10–06; 8:45 am] BILLING CODE 4163–18–P Dated: October 4, 2006. Alvin Hall, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. E6–16739 Filed 10–10–06; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Centers for Disease Control and Prevention CDC/HRSA Advisory Committee on HIV and STD Prevention and Treatment (CHACHSPT) National Institute for Occupational Safety and Health (NIOSH); Advisory Board on Radiation and Worker Health In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) and the Health Resources and Services Administration (HRSA) announce the following committee meeting. pwalker on PRODPC60 with NOTICES DEPARTMENT OF HEALTH AND HUMAN SERVICES In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention announces the following committee meeting: Name: CDC/HRSA Advisory Committee on HIV and STD Prevention and Treatment. Times and Dates: 8 a.m.–5 p.m., November 13, 2006. 8 a.m.–12:15 p.m., November 14, 2006. Place: Hotel Washington, 15th Street and Pennsylvania Avenue, NW., Washington, DC 20004, Telephone: 202–638–5900 or Fax 202–638–1594. Status: Open to the public, limited only by the space available. The meeting room will accommodate approximately 100 people. Purpose: This Committee is charged with advising the Secretary, the Director, CDC and the Administrator, HRSA, regarding activities related to prevention and control of HIV/ AIDS and other STDs, the support of health care services to persons living with HIV/ AIDS, and education of health professionals and the public about HIV/AIDS and other STDs. Matters To Be Discussed: Agenda items include issues pertaining to (1) HIV issues related to stigma, racism and discrimination and (2) Comprehensive adolescent sexual health and other HIV related issues. Agenda items are subject to change as priorities dictate. For Further Information Contact: Margie Scott-Cseh, Committee Management Specialist, National Center for HIV, STD, and TB Prevention, 1600 Clifton Road, NE., Mailstop E–07, Atlanta, Georgia 30333. Telephone: 404–639–8317, or Fax 404–639– 3125, e-mail zkr7@cdc.gov. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry. VerDate Aug<31>2005 16:53 Oct 10, 2006 Jkt 211001 Name: Advisory Board on Radiation and Worker Health, National Institute for Occupational Safety and Health. Time and Date: 10 a.m.–4 p.m., October 18, 2006. Place: Via Teleconference. For toll-free access, please dial 866–643–6504. Participant Pass Code 9448550. Status: Open to the public, but without a public comment period. Background: The Advisory Board was established under the Energy Employees Occupational Illness Compensation Program Act of 2000 to advise the President on a variety of policy and technical functions required to implement and effectively manage the new compensation program. Key functions of the Advisory Board include providing advice on the development of probability of causation guidelines that have been promulgated by the Department of Health and Human Services (HHS) as a final rule, advice on methods of dose reconstruction which have also been promulgated by HHS as a final rule, advice on the scientific validity and quality of dose estimation and reconstruction efforts being performed for purposes of the compensation program, and advice on petitions to add classes of workers to the Special Exposure Cohort. In December 2000, the President delegated responsibility for funding, staffing, and operating the Advisory Board to HHS, which subsequently delegated this authority to CDC. NIOSH implements this responsibility for CDC. The charter was issued on August 3, 2001, renewed at appropriate intervals, and will expire on August 3, 2007. Purpose: The Advisory Board is charged with (a) Providing advice to the Secretary, HHS, on the development of guidelines under Executive Order 13179; (b) providing advice to the Secretary, HHS, on the scientific validity and quality of dose reconstruction efforts performed for this program; and (c) upon request by the Secretary, HHS, advise the Secretary on whether there is a class of employees at any Department of Energy facility who were PO 00000 Frm 00079 Fmt 4703 Sfmt 4703 59793 exposed to radiation but for whom it is not feasible to estimate their radiation dose, and on whether there is reasonable likelihood that such radiation doses may have endangered the health of members of this class. Matters To Be Discussed: The agenda for the Advisory Board meeting includes Updates on Conflict of Interest Issues; Working Group Updates; Selection of Board Members for Individual Dose Reconstruction Reviews; Planning for Board Future Meetings and Activities; and Discussion of Past Public Comments and Possible Board Actions. The agenda is subject to change as priorities dictate. In the event an individual cannot attend, written comments may be submitted. Any written comments received will be provided at the meeting and should be submitted to the contact person below well in advance of the meeting. Due to programmatic matters, this Federal Register Notice is being published on less than 15 calendar days notice to the public (41 CFR 102–3.150(b)). Contact Person for More Information: Dr. Lewis V. Wade, Executive Secretary, NIOSH, CDC, 4676 Columbia Parkway, Cincinnati, Ohio 45226, telephone 513–533–6825, fax 513–533–6826. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry. Dated: October 4, 2006. Alvin Hall, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention (CDC). [FR Doc. E6–16747 Filed 10–10–06; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration Request for Nominations for Voting Members on Public Advisory Panels or Committees AGENCY: Food and Drug Administration, HHS. ACTION: Notice. SUMMARY: The Food and Drug Administration (FDA) is requesting nominations for voting members to serve on the Device Good Manufacturing Practice Advisory Committee, certain device panels of the Medical Devices Advisory Committee, the National Mammography Quality Assurance Advisory Committee, and the Technical Electronic Products Radiation Safety Standards Committee in the Center for Devices and Radiological Health. Nominations will be accepted E:\FR\FM\11OCN1.SGM 11OCN1

Agencies

[Federal Register Volume 71, Number 196 (Wednesday, October 11, 2006)]
[Notices]
[Page 59793]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E6-16739]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


CDC/HRSA Advisory Committee on HIV and STD Prevention and 
Treatment (CHACHSPT)

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) and the Health Resources and Services Administration 
(HRSA) announce the following committee meeting.

    Name: CDC/HRSA Advisory Committee on HIV and STD Prevention and 
Treatment.
    Times and Dates: 8 a.m.-5 p.m., November 13, 2006. 8 a.m.-12:15 
p.m., November 14, 2006.
    Place: Hotel Washington, 15th Street and Pennsylvania Avenue, 
NW., Washington, DC 20004, Telephone: 202-638-5900 or Fax 202-638-
1594.
    Status: Open to the public, limited only by the space available. 
The meeting room will accommodate approximately 100 people.
    Purpose: This Committee is charged with advising the Secretary, 
the Director, CDC and the Administrator, HRSA, regarding activities 
related to prevention and control of HIV/AIDS and other STDs, the 
support of health care services to persons living with HIV/AIDS, and 
education of health professionals and the public about HIV/AIDS and 
other STDs.
    Matters To Be Discussed: Agenda items include issues pertaining 
to (1) HIV issues related to stigma, racism and discrimination and 
(2) Comprehensive adolescent sexual health and other HIV related 
issues. Agenda items are subject to change as priorities dictate.
    For Further Information Contact: Margie Scott-Cseh, Committee 
Management Specialist, National Center for HIV, STD, and TB 
Prevention, 1600 Clifton Road, NE., Mailstop E-07, Atlanta, Georgia 
30333. Telephone: 404-639-8317, or Fax 404-639-3125, e-mail 
zkr7@cdc.gov.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining 
to announcements of meetings and other committee management 
activities, for both CDC and the Agency for Toxic Substances and 
Disease Registry.

    Dated: October 4, 2006.
Alvin Hall,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. E6-16739 Filed 10-10-06; 8:45 am]
BILLING CODE 4163-18-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.